In this episode, Northwestern University chemist Roel Templaar, PhD, gives a glimpse into the intricacies of quantum mechanics and its applications in nanotechnology. He explains how his work challenges classical theories, particularly in the field of chiral light-matter interactions.

In this episode, Northwestern Medicine neuro-oncologist, Priya Kumthekar, MD, discusses her pioneering work in nanomedicine on an early clinical trial in individuals with the deadly brain cancer glioblastoma. The study showed an experimental spherical nucleic acid drug, developed by Northwestern University scientists, was able to penetrate the blood-brain barrier and trigger the death of tumor cells. This was the first time a nanotherapeutic has been shown to cross the blood-brain barrier. The study set a precedent at Northwestern University and has opened the door for similar studies and innovations to take place here.

Moving the chemical and energy industries away from fossil fuel consumption is going to require effective and sustainable energy solutions. Northwestern University’s Dayne Swearer says nanotechnology is positioned to help make such solutions a reality. An assistant professor of Chemistry and a member of the IIN, Swearer’s lab is actively engaged in pioneering efforts in plasmonic nanoparticles and groundbreaking applications in renewable energy. In this episode, he talks about projects underway in his lab and how climate change issues help motivate him to make a contribution to science that will help make the world a better place for tomorrow.